SCHEMBL7927435

SCHEMBL7927435

Bc1ccc(Oc2ccnc(Cl)c2)c(C(=O)N(CC)CC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 1/20 0.38
SCN9A Q15858 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.36
NPC1 O15118 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 1/20 0.34
PDE4B Q07343 1/20 0.34
FLT1 P17948 1/20 0.33
KDR P35968 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1998955 0.86 ALDH1A1 (0.42) ALDH1A1MAPTL3MBTL1LMNASCN9A
SCHEMBL1997028 0.82 GRM5 (0.39) ALDH1A1MAPTL3MBTL1LMNASCN9A
SCHEMBL9326920 0.71 MEN1 (0.57) ALDH1A1MAPTL3MBTL1LMNASMN1; SMN2
SCHEMBL2370957 0.70 USP2 (0.42) ALDH1A1MAPTL3MBTL1LMNASCN9A
SCHEMBL9321390 0.69 ALDH1A1 (0.58) ALDH1A1MAPTL3MBTL1LMNASMN1; SMN2
SCHEMBL29693843 0.68 ALDH1A1 (0.60) ALDH1A1MAPTLMNAHPGDNPC1
SCHEMBL191586 0.67 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL6631074 0.66 CTNNB1 (0.58) MAPTLMNANPC1RAB9AKDM4E
SCHEMBL2518071 0.66 MAPT (0.65) ALDH1A1MAPTL3MBTL1LMNAHPGD
SCHEMBL471656 0.66 HPGD (0.50) ALDH1A1MAPTLMNASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010030954-A1 SPIRO-TETRACYCLIC RING COMPOUNDS AS BETASECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2010-03-18 WO disclosed